ClearPoint Neuro, Inc. (CLPT) Stock
Fundamentals
Recent news

ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
CLPT

ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
CLPT

ClearPoint Neuro Q2 Earnings Call Highlights
ClearPoint Neuro Q2 Earnings Call Highlights
CLPT

ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
CLPT
Technicals
Analyst Ratings
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of -$0.20 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
published over the past 14 days
Latest news

ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
CLPT

ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
CLPT

ClearPoint Neuro Q2 Earnings Call Highlights
ClearPoint Neuro Q2 Earnings Call Highlights
CLPT

ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
CLPT

Compared to Estimates, ClearPoint Neuro (CLPT) Q1 Earnings: A Look at Key Metrics
Compared to Estimates, ClearPoint Neuro (CLPT) Q1 Earnings: A Look at Key Metrics
CLPT

ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates
CLPT

ClearPoint Neuro Q1 Earnings Call Highlights
ClearPoint Neuro Q1 Earnings Call Highlights
CLPT

ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
CLPT

ClearPoint Neuro (CLPT) Moves 8.1% Higher: Will This Strength Last?
ClearPoint Neuro (CLPT) Moves 8.1% Higher: Will This Strength Last?
CLPT

CLPT Gets EU MDR Certification for ClearPoint Navigation Software
CLPT Gets EU MDR Certification for ClearPoint Navigation Software
CLPT
About ClearPoint Neuro, Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Joseph Michael Burnett | President, CEO & Director | 1977 |
| Mr. Danilo D'Alessandro | Chief Financial Officer | 1985 |
| Mr. Jeremy L. Stigall | Chief Business Officer | 1984 |
| Mr. Mazin Sabra | Chief Operating Officer | 1980 |
| Ms. Ellisa Cholapranee J.D. | General Counsel & Secretary | — |
| Mr. Robert C. Korn | Senior Vice President of Sales & Business Development | 1965 |
| Dr. Paul S. Larson FAANS, M.D. | Chief Medical Officer | — |
| Ms. Mary McNamara-Cullinane RAC | Senior Vice President of Regulatory Affairs | — |
| Ms. Megan Faulkenberry | Senior Vice President of Quality | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
Technicals
What the experts say
0 Wall Street Analyst Ratings
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +3.1 | -6.5 | -19.6 | -11.4 | ||||||||
| 2022 | -23.9 | -3.3 | +21.9 | -22.9 | +28.2 | +17.5 | +13.3 | -14.5 | -17.0 | -8.8 | -4.6 | -12.0 |
| 2023 | +14.3 | -9.8 | -7.2 | +18.7 | -23.4 | -5.9 | -3.1 | -15.9 | -12.7 | +14.6 | +1.4 | +14.1 |
| 2024 | +3.0 | -9.2 | +1.8 | -19.3 | +0.2 | -5.1 | +34.3 | +90.9 | -11.2 | +14.6 | -4.0 | +25.7 |
| 2025 | +12.4 | -14.3 | -12.3 | +9.9 | -15.1 | +1.3 | -7.6 | +4.9 | +108.9 | +11.0 | -23.9 | -0.4 |
| 2026 | -7.8 | -5.1 | -7.1 | +22.3 | +11.4 | +41.1 | -20.2 | -1.6 | -0.5 |



